Adamis Pharmaceuticals

About:

Adamis Pharmaceuticals is a neuro-biotechnology company developing treatments for neuro-based disorders.

Website: http://www.adamispharmaceuticals.com

Twitter/X: adamispharma

Description:

Adamis Pharmaceuticals is a clinical-stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a variety of neuro-based disorders with significant unmet medical needs. It commercializes products in various therapeutic areas, including allergy, opioid overdose, and respiratory and inflammatory diseases.

Total Funding Amount:

$75.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Diego, California, United States

Founded Date:

2006-01-01

Contact Email:

info(AT)adamispharma.com

Founders:

David J Marguglio, Dennis J. Carlo

Number of Employees:

11-50

Last Funding Date:

2023-08-04

IPO Status:

Public

Industries:

© 2025 bioDAO.ai